Author

Rong Li

First Affiliated Hospital of Guangzhou Medical UniversityORCID 0009-0002-0667-4367Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Rong Li6 papers · Dana-Farber Cancer Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Fanrui Zeng· 1 shared Lingge Zeng· 1 shared Man LiiD· 1 shared Xue SuniD· 1 shared Zhongliang Wang· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Fanrui Zeng

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PIEZO1 marks a low neuroendocrine state and supports cisplatin tolerance in small cell lung cancer

Zhongliang Wang, Lingge Zeng, Xue Sun, Man Li, Rong Li, Fanrui Zeng

This study identifies PIEZO1 as a marker of low neuroendocrine state and a contributor to cisplatin tolerance in SCLC through mechanistic and multi-omics analyses.

bioRxiv · Oct 13, 2026 · PreprintCancer Biology